NDC 71357-008 – Sodium Acetate
Sodium Acetate 200 meq/100mL · Injection, Solution, Concentrate · Intravenous
Product NDC71357-008
Product details
- Brand name
- Sodium Acetate
- Generic name
- Sodium Acetate Injection, USP, 200 mEq/100 mL
- Labeler
- MILLA PHARMACEUTICALS INC.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- ANDA · ANDA214805
- Marketed since
- October 25, 2024
- Listing expires
- December 31, 2027
Active ingredients
- Sodium Acetate 200 meq/100mL
Uses, dosage, side effects and warnings for Sodium Acetate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 71357-008-10 | 10 VIAL, PHARMACY BULK PACKAGE in 1 CASE (71357-008-10) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE (71357-008-01) | Oct 25, 2024 |
Other Sodium Acetate products
- 80830-2435 Sodium Acetate Anhydrous 164 mg/mL · Injection, Solution, Concentrate · Amneal Pharmaceuticals Private Limited
- 80830-2436 Sodium Acetate Anhydrous 164 mg/mL · Injection, Solution, Concentrate · Amneal Pharmaceuticals Private Limited
- 80830-2437 Sodium Acetate Anhydrous 164 mg/mL · Injection, Solution, Concentrate · Amneal Pharmaceuticals Private Limited
- 63323-032 Sodium Acetate 4 meq/100mL · Injection, Solution, Concentrate · Fresenius Kabi USA, LLC
- 0409-3299 Sodium Acetate Anhydrous 164 mg/mL · Injection, Solution, Concentrate · Hospira, Inc.
- 0409-7299 Sodium Acetate Anhydrous 3.28 g/20mL · Injection, Solution, Concentrate · Hospira, Inc.
- 71357-002 Sodium Acetate 164 mg/mL · Injection, Solution, Concentrate · MILLA PHARMACEUTICALS INC.
- 71357-007 Sodium Acetate 164 mg/mL · Injection, Solution, Concentrate · MILLA PHARMACEUTICALS INC.
- 71357-009 Sodium Acetate 400 meq/100mL · Injection, Solution, Concentrate · MILLA PHARMACEUTICALS INC.
- 0641-6261 Sodium Acetate Anhydrous 164 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6262 Sodium Acetate Anhydrous 164 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6263 Sodium Acetate Anhydrous 164 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.